Related Experiment Video
Updated: Jul 20, 2026
03:13
Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
Published on: June 28, 2024
[Esthesioneuroblastoma in children]
Jin Wang1, Rongguang Wang, Dongyi Han
1Department of Otolaryngology-Head and Neck Surgery, General Hospital of PLA, Beijing, 100853, China. wjkxqwhj@126.com
Lin Chuang Er Bi Yan Hou Ke Za Zhi = Journal of Clinical Otorhinolaryngology
|August 26, 2006
Summary
Esthesioneuroblastoma is a rare cancer in children and adolescents, often presenting with nasal symptoms and affecting the nasal cavity and skull base. Combined surgery and radiotherapy offer the best treatment approach for this rare condition.
Area of Science:
- Pediatric Oncology
- Head and Neck Surgery
- Neuro-oncology
Context:
- Esthesioneuroblastoma (ENB) is a rare malignant tumor originating from the olfactory epithelium.
- Pediatric ENB presents unique challenges due to the developing anatomy and potential long-term effects of treatment.
Purpose:
- To characterize the clinical presentation, treatment, and outcomes of esthesioneuroblastoma in pediatric and adolescent patients.
- To review the current literature and consolidate findings on pediatric ENB.
Summary:
- Retrospective analysis of pediatric patients (1993-2004) and literature review identified peak incidence in ages 11-15 years.
- Common symptoms include nasal obstruction, proptosis, epistaxis, and headache, with primary tumor sites in the nasal cavity, ethmoid sinus, orbit, and anterior cranial fossa.
- Treatment predominantly involved combined surgery and radiotherapy, though surgery alone was also used; mortality was often due to the primary tumor.
Impact:
- Highlights the rarity and aggressive nature of esthesioneuroblastoma in pediatric populations.
- Emphasizes the importance of multimodal treatment, particularly combined surgery and radiotherapy, for improved outcomes in pediatric ENB.
- Informs clinical decision-making and future research directions for this rare pediatric malignancy.
